Lozano R - Search Results

1

Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome.

Kaufmann WE, Raspa M, Bann CM, Gable JM, Harris HK, Budimirovic DB, Lozano R; FORWARD Consortium. Kaufmann WE, et al. Among authors: lozano r. J Autism Dev Disord. 2024 Feb;54(2):725-737. doi: 10.1007/s10803-022-05821-7. Epub 2022 Nov 28. J Autism Dev Disord. 2024. PMID: 36441429

2

Genomic studies in fragile X premutation carriers.

Lozano R, Hagerman RJ, Duyzend M, Budimirovic DB, Eichler EE, Tassone F. Lozano R, et al. J Neurodev Disord. 2014;6(1):27. doi: 10.1186/1866-1955-6-27. Epub 2014 Jul 30. J Neurodev Disord. 2014. PMID: 25170347 Free PMC article.

3

Modulation of the GABAergic pathway for the treatment of fragile X syndrome.

Lozano R, Hare EB, Hagerman RJ. Lozano R, et al. Neuropsychiatr Dis Treat. 2014 Sep 16;10:1769-79. doi: 10.2147/NDT.S42919. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25258535 Free PMC article. Review.

4

Translational research guided by animal studies in Fragile X Disorders.

Hagerman R, Lozano R, Schneider A. Hagerman R, et al. Among authors: lozano r. Intractable Rare Dis Res. 2014 Nov;3(4):100. doi: 10.5582/irdr.2014.01033. Intractable Rare Dis Res. 2014. PMID: 25606359 Free PMC article. No abstract available.

5

Fragile X spectrum disorders.

Lozano R, Rosero CA, Hagerman RJ. Lozano R, et al. Intractable Rare Dis Res. 2014 Nov;3(4):134-46. doi: 10.5582/irdr.2014.01022. Intractable Rare Dis Res. 2014. PMID: 25606363 Free PMC article. Review.

6

Participation of underrepresented minority children in clinical trials for Fragile X syndrome and other neurodevelopmental disorders.

Chechi T, Siyahian S, Thairu L, Hagerman R, Lozano R. Chechi T, et al. Among authors: lozano r. Intractable Rare Dis Res. 2014 Nov;3(4):147-52. doi: 10.5582/irdr.2014.01025. Intractable Rare Dis Res. 2014. PMID: 25606364 Free PMC article.

7

Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases.

Muzar Z, Adams PE, Schneider A, Hagerman RJ, Lozano R. Muzar Z, et al. Among authors: lozano r. Intractable Rare Dis Res. 2014 Nov;3(4):162-5. doi: 10.5582/irdr.2014.01023. Intractable Rare Dis Res. 2014. PMID: 25606366 Free PMC article.

8

Parent-delivered touchscreen intervention for children with fragile X syndrome.

Díez-Juan M, Schneider A, Phillips T, Lozano R, Tassone F, Solomon M, Hagerman RJ. Díez-Juan M, et al. Among authors: lozano r. Intractable Rare Dis Res. 2014 Nov;3(4):166-77. doi: 10.5582/irdr.2014.01026. Intractable Rare Dis Res. 2014. PMID: 25606367 Free PMC article.

9

Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Lozano R, Martinez-Cerdeno V, Hagerman RJ. Lozano R, et al. Curr Pharm Des. 2015;21(34):4972-4979. doi: 10.2174/1381612821666150914121038. Curr Pharm Des. 2015. PMID: 26365141 Free PMC article. Review.

10

Aging in Fragile X Premutation Carriers.

Lozano R, Saito N, Reed D, Eldeeb M, Schneider A, Hessl D, Tassone F, Beckett L, Hagerman R. Lozano R, et al. Cerebellum. 2016 Oct;15(5):587-94. doi: 10.1007/s12311-016-0805-x. Cerebellum. 2016. PMID: 27334385 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters